Cash and Cash Equivalents, at Carrying Value in USD of Pelthos Therapeutics Inc. from Q4 2022 to Q3 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.
Summary
Pelthos Therapeutics Inc. quarterly Cash and Cash Equivalents, at Carrying Value history and change rate from Q4 2022 to Q3 2025.
  • Pelthos Therapeutics Inc. Cash and Cash Equivalents, at Carrying Value for the quarter ending 30 Sep 2025 was $14.2M.
Cash and Cash Equivalents, at Carrying Value, Quarterly (USD)
Cash and Cash Equivalents, at Carrying Value, YoY Quarterly Change (%)

Pelthos Therapeutics Inc. Quarterly Cash and Cash Equivalents, at Carrying Value (USD)

Period Value YoY Chg Change % Date Report Filed
Q3 2025 $14.2M 30 Sep 2025 10-Q 13 Nov 2025
Q2 2025 $100K 30 Jun 2025 10-Q 13 Aug 2025
Q1 2024 $3.8M 31 Mar 2024 10-Q 15 May 2024
Q4 2023 $100K $0 0% 31 Dec 2023 10-Q 13 Nov 2024
Q4 2022 $100K 31 Dec 2022 10-K 16 Apr 2024
* An asterisk sign (*) next to the value indicates that the value is likely invalid.